Fig. 5From: In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune responseImmune responses and immunogenic cell death induced by the chemoimmunotherapy hydrogel. Representative flow cytometry images (A) and proportions (B) of mature DCs (mDCs, CD11c+CD80+CD86+) in tumor-draining lymph nodes (TDLNs) 1 week after the last treatment (n = 5). The error bars represented mean ± SEM. p-values were calculated by two-tailed unpaired Student’s t-tests. ns P > 0.05, **P = 0.0011 and ***P = 0.0003, ****P < 0.0001. Representative flow cytometry images (C) and proportions (D) of effector memory T cells (TEM, CD3+CD8+CD44+CD62L–) and central memory T cells (TCM, CD3+CD8+CD44+CD62L+) in tumors 1 week after the last treatment (n = 5). The error bars represented mean ± SEM. p-values were calculated by two-tailed unpaired Student’s t-tests. *P = 0.0102 (TEM) 0.0333 (TCM), **P = 0.0032 (NS vs R837/ALG) 0.0049 (NS vs Nab-PTX/ALG) 0.0033 (Nab-PTX/ALG vs R837/Nab-PTX/ALG) and ***P = 0.0002. Representative flow cytometry images (E) and proportions (F) of cytotoxic lymphocytes (CTLs, CD3+CD8+) and helper T cells (Th, CD3+CD4.+) in spleens 1week after the last treatment (n = 5). The error bars represented mean ± SEM. p-values were calculated by two-tailed unpaired Student’s t-tests. *P = 0.0276 (CD4) 0.0145 (CD8), **P = 0.0063 (CD4), ***P = 0.0004 (NS vs R837/ALG) 0.005 (ALG vs R837/Nab-PTX/ALG) 0.0002 (NS vs R837/Nab-PTX/ALG). (G) Calreticulin (CRT) staining of tumors (brown) 1 week after the last treatment (the scale bar is 62.5 µm and 20 µm, respectively)Back to article page